Dow Jones 30 Stocks SEC Filings — February 16, 2026

17-02-2026

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-007204), reporting under Item 2.02 for Results of Operations and Financial Condition. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a single-item, mandatory disclosure typical for financial results announcements.

17-02-2026

EKSO Bionics Holdings, Inc. filed a multi-item Form 8-K on February 17, 2026, disclosing events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative impacts are disclosed. The combination of control changes, equity sales, and governance modifications suggests potential strategic shifts, dilution risks, and operational updates without further details provided.

17-02-2026

Labcorp Holdings Inc. filed an 8-K on February 17, 2026 (AccNo: 0000920148-26-000098), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

17-02-2026

Global Business Travel Group, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001104659-26-015928, Size: 279 KB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are detailed in the filing information provided. This appears to be a standard earnings-related disclosure without quantified metrics.

17-02-2026

AMERICAN EXPRESS CO filed an 8-K on February 17, 2026 (AccNo: 0000004962-26-000102, Size: 221 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, period-over-period comparisons, or other quantitative data are explicitly stated in the provided filing information. This appears to be a single-item, voluntary disclosure with no directional implications discernible from the summary.

17-02-2026

Republic Services, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001060391-26-000093), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, margins, guidance, or other quantitative metrics are provided in the filing description. No positive or negative performance indicators are available.

17-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on 2026-02-17 (AccNo: 0001104659-26-016379) disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, values, terms, financial metrics, synergies, or impacts are detailed.

• ·Accession Number: 0001104659-26-016379
• ·Filing size: 1 MB
• ·Sector: not specified

17-02-2026

RB Global Inc. filed a Form 8-K on February 17, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This multi-item filing is typical for earnings releases but lacks quantitative metrics or performance indicators.

17-02-2026

Airship AI Holdings, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001654954-26-001312), under Item 2.02 disclosing results of operations and financial condition, Item 7.01 for Regulation FD disclosure, and Item 9.01 for financial statements and exhibits. This is a multi-item voluntary furnished filing typical for earnings pre-announcements, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed. No positive, negative, or flat metrics provided.

17-02-2026

17-02-2026

Knife River Corp filed a Form 8-K on February 17, 2026 (AccNo: 0001628280-26-008306), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This multi-item filing pertains to financial results with no specific revenue, earnings, margins, or period-over-period metrics provided. Detailed quantitative data, guidance, or performance variances are NOT_DISCLOSED.

17-02-2026

MAINZ BIOMED N.V. filed a multi-item Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departure/election of directors or officers and compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including transaction values, share counts, financial impacts, dollar amounts, or quantitative metrics are NOT_DISCLOSED. The combination of potential strategic agreement alongside equity issuances and rights changes suggests mixed implications, but lacks quantification for assessment.

17-02-2026

17-02-2026

Honeywell International Inc filed a Form 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure to comply with Regulation FD, with exhibits attached, but no specific financial metrics, transactions, or performance data are detailed. No positive or negative metrics are disclosed, providing only structural filing information.

17-02-2026

National Energy Services Reunited Corp. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006872), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or other metrics are provided in the filing summary. No positive or negative performance indicators, guidance, or comparisons are detailed.

17-02-2026

Cineverse Corp. disclosed entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), representing a key strategic transaction; however, it also created a direct financial obligation (Item 2.03) and involved unregistered sales of equity securities (Item 3.02), potentially introducing leverage and dilution risks. Regulation FD disclosure was provided (Item 7.01) with financial statements and exhibits (Item 9.01). No specific deal terms, parties, values, or financial metrics are disclosed.

17-02-2026

JFB Construction Holdings filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006871), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, or any financial metrics are disclosed. Sector information is not specified.

• ·Filing date: 2026-02-17
• ·Accession Number: 0001493152-26-006871
• ·File size: 208 KB
• ·Event type: Officer Change

17-02-2026

Leidos Holdings, Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative data are disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no directional performance indicators available.

17-02-2026

Datavault AI Inc. filed a Form 8-K on February 17, 2026, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This multi-item filing announces financial results with attached exhibits. No specific revenue, earnings, comparisons, guidance, or other quantitative metrics are disclosed.

17-02-2026

nVent Electric plc filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction size, parties, financial impacts, or quantitative metrics are provided.

17-02-2026

BioRestorative Therapies, Inc. filed an 8-K on 2026-02-17 reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

17-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any exhibits are provided. No quantitative metrics, positive or negative changes, or financial impacts are mentioned.

17-02-2026

CNH Industrial N.V. filed an 8-K on 2026-02-17 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 8.01 (Other Events), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. This is a multi-item voluntary disclosure typical for earnings releases.

17-02-2026

Herc Holdings Inc filed a Form 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item earnings-related filing, but specific revenue, earnings, guidance, or other quantitative financial metrics are NOT_DISCLOSED. No positive or negative performance indicators, period-over-period comparisons, or material events with dollar values were detailed in the provided filing information.

17-02-2026

InfuSystem Holdings, Inc. filed a Form 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure. This voluntary filing discloses material non-public information to comply with Regulation FD requirements. No specific financial metrics, transactions, events, or quantitative data are detailed in the provided filing information.

17-02-2026

AG Mortgage Investment Trust, Inc. filed a Form 8-K on February 17, 2026, reporting solely under Item 8.01 Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

17-02-2026

TE Connectivity plc filed an 8-K on February 17, 2026, reporting under Item 1.01 the entry into a material definitive agreement, under Item 1.02 the termination of a material definitive agreement, and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, positive or negative metrics, or directional changes were disclosed.

17-02-2026

Kennedy-Wilson Holdings, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, events, or exhibits are provided in the filing summary. No quantitative financial metrics, period-over-period comparisons, or directional impacts are mentioned.

17-02-2026

Vulcan Materials Company filed an 8-K on February 17, 2026 (AccNo: 0001140361-26-005605), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely related to earnings or operational updates, but no specific financial metrics, positive or negative changes, guidance, or transaction details are disclosed in the provided information. All quantitative data and performance comparisons remain NOT_DISCLOSED.

17-02-2026

Science Applications International Corp filed an 8-K on 2026-02-17 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or market impacts are mentioned.

17-02-2026

Coronado Global Resources Inc. filed an 8-K on February 17, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, financial statements, exhibits, or any metrics are provided in the filing summary. This appears to be a voluntary disclosure of material information pursuant to Regulation FD.

17-02-2026

Valmont Industries Inc filed a Form 8-K on 2026-02-17 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. This is a standard voluntary earnings disclosure with no quantitative metrics extracted.

17-02-2026

CEVA INC filed an 8-K on February 17, 2026 (AccNo: 0001437749-26-004232), reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. This constitutes a multi-item filing for financial results disclosure. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

• ·Sector: not specified
• ·Source: us_sec
• ·File size: 548 KB

17-02-2026

Kyndryl Holdings, Inc. filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected (e.g., CEO, CFO), names, reasons for changes, timing, or impacts are provided in the filing summary. No quantitative data, financial metrics, or scheduled events are mentioned.

17-02-2026

Soluna Holdings, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001493152-26-006929, Size: 272 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the exhibits are provided in the filing summary. No financial metrics, transactions, or other quantitative data are disclosed.

17-02-2026

M3-Brigade Acquisition V Corp. filed an 8-K on 2026-02-17 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific merger/acquisition details, transaction values, parties involved, financial metrics, or period-over-period comparisons were explicitly stated in the filing information provided. Sector was not specified.

17-02-2026

Disc Medicine, Inc. filed a Form 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure, indicating voluntary release of material nonpublic information, and Item 9.01 Financial Statements and Exhibits, likely attaching related materials such as a press release. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing information. Details of the disclosure content remain NOT_DISCLOSED.

17-02-2026

FiscalNote Holdings, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053083, Size: 183 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the Regulation FD disclosure content, financial statements, exhibits, transactions, metrics, or events are provided in the filing summary. This appears to be a multi-item informational filing with no disclosed quantitative data or directional impacts.

17-02-2026

Intellinetics, Inc. filed a Form 8-K on 2026-02-17 disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for most items, but no specific details on the agreement, obligation size, officer changes, dollar values, strategic rationale, or quantitative impacts are provided. No positive, negative, or flat metrics are mentioned.

17-02-2026

Invech Holdings, Inc. filed a Form 8-K on February 17, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), and 9.01 (Financial Statements and Exhibits). No specific details on transaction values, parties involved, financial impacts, or changes are provided in the filing summary. This multi-item filing indicates a potentially transformative corporate event such as a merger or acquisition leading to control changes, but lacks quantitative data for assessment.

17-02-2026

Investors Title Co filed an 8-K on February 17, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics were explicitly stated in the provided filing details. This appears to be a standard voluntary earnings-related disclosure without detailed performance data.

17-02-2026

Cooper-Standard Holdings Inc. filed an 8-K on February 17, 2026, reporting Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the filing summary. This is an informational filing with no quantified financial metrics, positive or negative changes reported.

17-02-2026

VisionWave Holdings, Inc. filed a Form 8-K on 2026-02-17 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, strategic rationale, or any quantitative metrics are disclosed.

17-02-2026

Marriott Vacations Worldwide Corp filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer's name, title, reason for departure or appointment, effective date, or internal/external status are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

17-02-2026

ServiceNow, Inc. filed an 8-K on February 17, 2026, specifically under Item 7.01 Regulation FD Disclosure. No quantitative financial metrics, transaction details, guidance changes, or operational data were explicitly stated in the filing information provided. The filing has Accession Number 0001373715-26-000014 and size of 141 KB, with sector not specified.

17-02-2026

PPLUS Trust Series GSC-2 filed a Form 8-K on February 17, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This is a multi-item voluntary filing with no quantitative metrics or directional impacts provided.

17-02-2026

VirTra, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006967), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on key positions affected, individuals, appointment/resignation status, reasons, timing, or governance implications were provided. No quantitative data, financial metrics, or scheduled events were mentioned.

17-02-2026

Xerox Holdings Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053333), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or metrics provided in the filing summary. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.

17-02-2026

SAN JUAN BASIN ROYALTY TRUST filed an 8-K on February 17, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, distributions, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard informational filing for operational results with no disclosed directional impacts.

17-02-2026

Permian Basin Royalty Trust filed an 8-K on February 17, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information.

17-02-2026

Apple iSports Group, Inc. filed an 8-K on 2026-02-17 disclosing under Item 1.01 its entry into a material definitive agreement. No details regarding the nature of the agreement, counterparties, dollar value, financial terms, or strategic implications are provided in the filing summary. This is a single-item filing with no quantitative metrics, guidance changes, or scheduled events mentioned.

17-02-2026

FIDUS INVESTMENT Corp filed an 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, transactions, financial metrics, or events are disclosed in the provided filing summary. This appears to be a voluntary disclosure with attached exhibits, but content is NOT_DISCLOSED.

17-02-2026

Clearwater Analytics Holdings, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001866368-26-000004, Size: 158 KB), reporting solely under Item 7.01 Regulation FD Disclosure. This is a single-item voluntary filing with no specific details on the disclosed information, financial metrics, transactions, or events provided. No quantitative data, positive or negative metrics, or forward-looking statements are mentioned.

17-02-2026

AIxCrypto Holdings, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, financial impacts, or specific changes are provided in the filing summary.

17-02-2026

17-02-2026

RAVE RESTAURANT GROUP, INC. filed an 8-K on February 17, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits related to the change. No details on the accountants involved, reasons for the change, financial impacts, or other metrics are explicitly stated.

17-02-2026

Yorkville Acquisition Corp. filed an 8-K on 2026-02-17 disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02. Item 9.01 includes financial statements and exhibits. No quantitative metrics, deal terms, parties, or performance comparisons are disclosed, resulting in no identifiable positive or negative impacts.

17-02-2026

Innventure, Inc. filed an 8-K on February 17, 2026 (AccNo: 0002001557-26-000020, Size: 160 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are detailed in the provided filing information. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance.

17-02-2026

TRUSTCO BANK CORP N Y filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events and the financial statements or exhibits are NOT_DISCLOSED. No quantitative metrics, transactions, or strategic implications are provided in the filing summary.

17-02-2026

Safe & Green Development Corp filed a Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This multi-item filing signals a significant transaction involving financing or partnership activity, but no specific dollar values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in no directional bias.

17-02-2026

Travelers Companies, Inc. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

17-02-2026

Devon Energy Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054657), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with exhibits attached.

• ·Filing size: 860 KB
• ·Source: US SEC
• ·Sector: not specified

17-02-2026

Howard Hughes Holdings Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 1.02 termination of a prior material definitive agreement, representing a multi-item filing with mixed implications. Item 8.01 discloses other events, while Item 9.01 includes financial statements and exhibits. No specific details, transaction values, financial impacts, or quantitative metrics are disclosed.

17-02-2026

Veradigm Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed operational or financial data available.

• ·AccNo: 0001193125-26-054612
• ·File size: 699 KB
• ·Sector: not specified

17-02-2026

Diamond Hill Investment Group Inc filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are provided in the filing summary. No financial metrics, transactions, or directional impacts are disclosed.

17-02-2026

Glaukos Corp filed a Form 8-K on 2026-02-17 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are mentioned.

17-02-2026

Star Holdings filed a Form 8-K on February 17, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached financials.

17-02-2026

Luvu Brands, Inc. filed an 8-K on 2026-02-17 reporting the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 provides financial statements and exhibits. No specific transaction details, financial metrics, parties involved, or values are disclosed.

17-02-2026

Advanced Micro Devices Inc. filed an 8-K on February 17, 2026 (AccNo: 0000002488-26-000029), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a routine SEC-required disclosure for leadership changes with no additional quantitative or qualitative context provided.

17-02-2026

TPG RE Finance Trust, Inc. filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, or period-over-period comparisons are disclosed in the provided filing information. Detailed quantitative metrics and guidance are NOT_DISCLOSED.

17-02-2026

Rush Street Interactive, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001793659-26-000003, Size: 543 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results, but specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided information. No positive or negative metrics, strategic events, or scheduled follow-ups are mentioned.

17-02-2026

BullFrog AI Holdings, Inc. filed an 8-K on 2026-02-17 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 includes Financial Statements and Exhibits. No additional financial metrics, reasons for delisting, or quantitative impacts are disclosed.

17-02-2026

DeFi Development Corp. filed an 8-K on February 17, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. This appears to be a voluntary informational disclosure with no quantified positive or negative impacts mentioned.

17-02-2026

Elite Pharmaceuticals Inc. /NV/ filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-007190), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing typical for earnings releases, but no specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided information. Sector is not specified.

17-02-2026

GREAT SOUTHERN BANCORP, INC. filed a Form 8-K on February 17, 2026 (AccNo: 0001171843-26-000861, size: 218 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. This appears to be a multi-item informational filing with no quantified metrics or directional impacts provided.

17-02-2026

Equity Bancshares Inc filed a Form 8-K on 2026-02-17 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), with Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event involving a new agreement and financial obligation. No quantitative details, transaction values, parties, impacts, or performance metrics (positive, negative, or flat) are disclosed.

• ·AccNo: 0001193125-26-054930
• ·File Size: 298 KB

17-02-2026

Kenvue Inc. filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02 alongside costs associated with exit or disposal activities under Item 2.05, indicating potential restructuring expenses. Financial statements and exhibits are included under Item 9.01. No specific financial metrics, performance comparisons, or impacts are disclosed in the provided filing summary.

17-02-2026

Falcon's Beyond Global, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.

17-02-2026

Inuvo, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 references Financial Statements and Exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided.

17-02-2026

Aptiv PLC filed a Form 8-K on February 17, 2026, under Item 8.01 Other Events, which is a catch-all for material events not covered by other specific items. No details on the core event, financial impacts, transaction values, or operational metrics are explicitly stated in the provided filing information. All quantitative data and specifics are NOT_DISCLOSED.

17-02-2026

Civista Bancshares, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 5.08 regarding shareholder nominations pursuant to Exchange Act Rule 14a-11 and under Item 8.01 other events. No quantitative financial metrics, transaction values, or performance comparisons were disclosed. This is a multi-item procedural filing with no indicated positive or negative impacts.

17-02-2026

PSQ Holdings, Inc. filed a Form 8-K on 2026-02-17 under Accession No. 0001104659-26-016552 (297 KB), reporting a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01. The multi-item filing also includes Item 2.02 on results of operations and financial condition and Item 9.01 for financial statements and exhibits. No specific financial metrics, reasons for delisting, transaction values, or quantitative impacts are disclosed.

17-02-2026

MarketAxess Holdings Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-055003), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names of individuals, reasons for the change, effective dates, or any financial metrics are provided. No quantitative data, performance comparisons, or other material impacts are mentioned.

17-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-17 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, deal structure details, parties involved, or merger/acquisition specifics are disclosed in the filing summary. Sector is not specified.

17-02-2026

HOOKER FURNISHINGS Corp filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial metrics, or impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure.

17-02-2026

Ovintiv Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-055088, Size: 198 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or directional information are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with attached exhibits.

17-02-2026

Valaris Ltd filed an 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, metrics, transactions, or content of the disclosure or exhibits are disclosed in the provided filing information.

17-02-2026

DIRTT Environmental Solutions Ltd filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-055157), reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. This is a multi-item filing with no specific transaction details, financial metrics, dollar values, or named individuals disclosed. No positive or negative performance metrics were provided, preventing assessment of directional impact.

17-02-2026

GeoVax Labs, Inc. filed an 8-K on February 17, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Regulation FD disclosure is provided under Item 7.01, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period metrics are disclosed.

17-02-2026

Bally's Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are disclosed.